Literature DB >> 34167587

Evaluation of pharmacy-led weight management service to minimise the risk of cardiovascular disease.

Aliki Peletidi1,2, Reem Kayyali3.   

Abstract

AIMS: The primary aim of the programme was a minimum of a 5% weight reduction of the initial weight, while the secondary outcomes were a reduction in participants' body mass index (BMI), waist circumference (WC), blood pressure (BP), AUDIT-C score and an increase in the Mediterranean diet (MD) score and an improvement in physical activity levels.
METHODS: This 'before and after' study was a 10-week weight management (WM) programme and it was developed and delivered in community pharmacies in Patras chosen for convenience, thus consisting the first service of its type in Greece. The sample size was calculated (n = 96) based on the mean BMI for a Greek male and female individual, and the standard deviation (SD) of weight at baseline of 14 kg.
RESULTS: Nearly every participant enrolled in the 20 participating pharmacies, 97.4% (n = 114/117), achieved the programme's aim, losing at least 5% of their initial weight. The mean percentage of total weight loss of the 117 participants at the 10th week was 8.97% (SD 2.65), and the t-test showed statistically significant results (P-value < 0.001; 95% CI [8.48, 9.45]). A significant reduction in the waist-to-height ratio (WHtR) was observed in both male (P-value = 0.004) and female (P-value < 0.001) participants. The participants' BP and AUDIT-C score and physical activity levels significantly improved (P-value < 0.001), as well as their MD score.
CONCLUSION: This study provides the first evidence that Greek pharmacists have the potential to play an important role within primary healthcare and that after training they are able to provide public health services for both the public's benefit and their clinical role enhancement.

Entities:  

Keywords:  CVD prevention; Community pharmacy; Greek pharmacists’ new clinical role; Pharmacy-led weight management programme; Preventive cardiology; Public health

Year:  2021        PMID: 34167587     DOI: 10.1186/s40545-021-00338-3

Source DB:  PubMed          Journal:  J Pharm Policy Pract        ISSN: 2052-3211


  33 in total

1.  Ratio of waist circumference to height is strong predictor of intra-abdominal fat.

Authors:  M Ashwell; T J Cole; A K Dixon
Journal:  BMJ       Date:  1996-08-31

2.  [The toxicity of cadmium].

Authors:  F K Ohnesorge
Journal:  Schriftenr Ver Wasser Boden Lufthyg       Date:  1973

Review 3.  A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value.

Authors:  Lucy M Browning; Shiun Dong Hsieh; Margaret Ashwell
Journal:  Nutr Res Rev       Date:  2010-09-07       Impact factor: 7.800

4.  A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women.

Authors:  Helmut Schröder; Montserrat Fitó; Ramón Estruch; Miguel A Martínez-González; Dolores Corella; Jordi Salas-Salvadó; Rosa Lamuela-Raventós; Emilio Ros; Itziar Salaverría; Miquel Fiol; José Lapetra; Ernest Vinyoles; Enrique Gómez-Gracia; Carlos Lahoz; Lluis Serra-Majem; Xavier Pintó; Valentina Ruiz-Gutierrez; María-Isabel Covas
Journal:  J Nutr       Date:  2011-04-20       Impact factor: 4.798

5.  Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis.

Authors:  A M Dattilo; P M Kris-Etherton
Journal:  Am J Clin Nutr       Date:  1992-08       Impact factor: 7.045

Review 6.  Obesity and hypertension: epidemiological and clinical issues.

Authors:  S MacMahon; J Cutler; E Brittain; M Higgins
Journal:  Eur Heart J       Date:  1987-05       Impact factor: 29.983

7.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

8.  A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial.

Authors:  Miguel Angel Martínez-González; Ana García-Arellano; Estefanía Toledo; Jordi Salas-Salvadó; Pilar Buil-Cosiales; Dolores Corella; Maria Isabel Covas; Helmut Schröder; Fernando Arós; Enrique Gómez-Gracia; Miquel Fiol; Valentina Ruiz-Gutiérrez; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Miguel Angel Muñoz; Julia Wärnberg; Emilio Ros; Ramón Estruch
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

9.  Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly.

Authors:  Anna Karla Carneiro Roriz; Luiz Carlos Santana Passos; Carolina Cunha de Oliveira; Michaela Eickemberg; Pricilla de Almeida Moreira; Lílian Ramos Sampaio
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

10.  Prospective association of the Mediterranean diet with cardiovascular disease incidence and mortality and its population impact in a non-Mediterranean population: the EPIC-Norfolk study.

Authors:  Tammy Y N Tong; Nicholas J Wareham; Kay-Tee Khaw; Fumiaki Imamura; Nita G Forouhi
Journal:  BMC Med       Date:  2016-09-29       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.